Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FP8GY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,802
Award facts
- Contract value 100% obligated
- $16,801.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,801.93 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in a 2-pen/mL formulation, with an ultimate completion date of January 2, 2026. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare programs. The company's established track record with DLA demonstrates capability in delivering specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains through competitive procurement processes. This delivery order for Cosentyx, an immunosuppressant used in treating autoimmune conditions, exemplifies the company's role in supplying essential specialty pharmaceuticals to support federal medical supply chain requirements.
Quick answers
Who was awarded contract SPE2DR26FP8GY?
SPE2DR26FP8GY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FP8GY worth?
The government has obligated $16,802 on SPE2DR26FP8GY.
Is contract SPE2DR26FP8GY an order under another contract?
Yes. SPE2DR26FP8GY is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8GY competed?
The extent of competition for SPE2DR26FP8GY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award